DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rha, Min-Seok | ko |
dc.contributor.author | Kim, A. Reum | ko |
dc.contributor.author | Shin, Eui-Cheol | ko |
dc.date.accessioned | 2021-04-05T05:10:16Z | - |
dc.date.available | 2021-04-05T05:10:16Z | - |
dc.date.created | 2021-04-05 | - |
dc.date.created | 2021-04-05 | - |
dc.date.created | 2021-04-05 | - |
dc.date.issued | 2021-02 | - |
dc.identifier.citation | IMMUNE NETWORK, v.21, no.1 | - |
dc.identifier.issn | 1598-2629 | - |
dc.identifier.uri | http://hdl.handle.net/10203/282298 | - |
dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19), an ongoing pandemic disease. In the current review, we describe SARS-CoV-2-specific CD4(+) and CD8(+) T-cell responses in acute and convalescent COVID-19 patients. We also discuss the relationships between COVID-19 severity and SARS-CoV-2-specific T-cell responses and summarize recent reports regarding SARS-CoV-2-reactive T cells in SARS-CoV-2-unexposed individuals. These T cells may be cross-reactive cells primed by previous infection with human common-cold coronaviruses. Finally, we outline SARS-CoV-2-specific T-cell responses in the context of vaccination. A better understanding of SARS-CoV-2-specific T-cell responses is needed to develop effective vaccines and therapeutics. | - |
dc.language | English | - |
dc.publisher | KOREA ASSOC IMMUNOLOGISTS | - |
dc.title | SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals | - |
dc.type | Article | - |
dc.identifier.wosid | 000626257600002 | - |
dc.identifier.scopusid | 2-s2.0-85102744203 | - |
dc.type.rims | ART | - |
dc.citation.volume | 21 | - |
dc.citation.issue | 1 | - |
dc.citation.publicationname | IMMUNE NETWORK | - |
dc.identifier.doi | 10.4110/in.2021.21.e2 | - |
dc.identifier.kciid | ART002692696 | - |
dc.contributor.localauthor | Shin, Eui-Cheol | - |
dc.description.isOpenAccess | Y | - |
dc.type.journalArticle | Review | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | T cell | - |
dc.subject.keywordPlus | EFFECTOR | - |
dc.subject.keywordPlus | EPITOPES | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.